MicroRNA-21 in gynecological cancers: From molecular pathogenesis to clinical significance.

Abstract

Ovarian, cervical, and endometrial cancers are the three most common gynecological cancer types (GCs). They hold a significant position as the leading causes of mortality among women with cancer-related death. However, GCs are often diagnosed late, severely limiting the efficacy of current treatment options. Thus, there is an urgent, unmet need for innovative experimentation to enhance the clinical treatment of GC patients. MicroRNAs (miRNAs) are a large and varied class of short noncoding RNAs (22 nucleotides in length) that have been shown to play essential roles in various biological processes involved in development. Recent research has shown that miR-211 influences tumorigenesis and cancer formation, adding to our knowledge of the miR-21 dysregulation in GCs. Furthermore, current research that sheds light on the crucial functions of miR-21 may provide supporting evidence for its potential prognostic, diagnostic, and therapeutic applications in the context of GCs. This review will thus focus on the most recent findings concerning miR-21 expression, miR-21 target genes, and the processes behind GCs. In addition, the latest findings that support miR-21's potential use as a non-invasive biomarker and therapeutic agent for detecting and treating cancer will be elucidated in this review. The roles played by various lncRNA/circRNA-miRNA-mRNA axis in GCs are also comprehensively summarized and described in this study, along with any possible implications for how these regulatory networks may contribute to the pathogenesis of GCs. Also, it is crucial to recognize the complexity of the processes involved in tumour therapeutic resistance as a significant obstacle in treating GCs. Furthermore, this review provides an overview of the current state of knowledge regarding the functional significance miR-21 in therapeutic resistance within the context of GCs.

• Authors: Ni-Jie Jiang, Ya-Nan Yin, Jiao Lin, Wen-Yuan Li, De-Rong Long, Ling Mei
• Journal: Pathology, research and practice (Pathol Res Pract) Vol. 248 Pg. 154630 (Aug 2023) ISSN: 1618-0631 [Electronic] Germany
• PMID: 37393665 (Publication Type: Journal Article, Review)
• Copyright: Copyright © 2023 Elsevier GmbH. All rights reserved.

Chemical References

• MicroRNAs
• MIRN21 microRNA, human

Topics

• Humans
• Female
• Clinical Relevance
• MicroRNAs (metabolism)
• Endometrial Neoplasms (genetics)
• Prognosis